TNF and psoriasis: Specifically, polymorphisms of the CTLA4 (rs3087243), FBXL19 (rs10782001), SLC12A8 (rs651630), and TAP1 (rs1800453) genes have shown an association with susceptibility to developing toxicity and/or paradoxical psoriasis due to anti-TNF drugs [101].